Skip to main content
Log in

Plasma lysosomal enzyme levels in patients with motor neuron disease

  • Published:
Journal of Inherited Metabolic Disease

Summary

β-Hexosaminidase and acid-α-mannosidase were estimated in 17 adult patients with motor neuron disease. Normal plasma levels of β-hexosaminidase ((A+B) and A) were found in all patients studied. Plasma acid α-mannosidase levels were normal in all but two patients with the spinal muscular atrophy type of the disorder. In addition, altered biochemical properties of acid α-mannosidase (i.e.K m, thermal stability) were found in the low-activity cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bayleran J, Hechtman P, Saray W (1984) Synthesis of 4-methylumbelliferyl-β-d-N-acetylglucosamine-5-sulfate and its use in classification of GM2-gangliosidosis genotypes.Clin Chim Acta 143: 73–91.

    Google Scholar 

  • Caroscio J, Mulvihill M, Sterling R, Abram R (1987) Amyotrophic lateral sclerosis: its natural history.Neurol Clin 5: 1–8.

    Google Scholar 

  • Conzelmann E, Sandhoff K (1984) Partial enzyme deflciencies, residual activities and the development of neurological disorders.Dev Neurosci 6: 58–71.

    Google Scholar 

  • Drachman DB, Kuncl RW (1986) Amyotrophic lateral sclerosis: an unconventional autoimmune disease?Ann Neurol 26: 269–274.

    Google Scholar 

  • Federico A, Palmeri S, Mangano L, Mondelli M, Rossi A, Guazzi G (1987) Clinical and neurophysiological changes in carriers from a family with type O chronic GM2-gangliosidosis with ALS phenotype. In Salvayre R, Douste-Blazy L, Gatt S, eds.Lipid Storage Disorders. Biological and Medical Aspects. NAT ASI Series vol. 150. New York: Plenum Press, 253–258.

    Google Scholar 

  • Hirani S, Winchester BG, Patrick AD (1977) Measurement of the α-mannosidase activities in human plasma by a differential assay.Clin Chim Acta 81: 135–144.

    Google Scholar 

  • Martin JB (1993) Molecular genetics in neurology.Ann Neurol 34: 757–773.

    Google Scholar 

  • Mitsumoto H, Sliman RJ, Schafer LA et al (1985) Motor neuron disease and adult hexosaminidase A deflciency in two families: evidence for multisystem degeneration.Ann Neurol 17: 378–385.

    Google Scholar 

  • Mitsumoto H, Hanson MR, Chad DA (1988) Amyotrophic lateral sclerosis; recent advances in pathogenesis and therapeutic trials.Arch Neurol 45: 189–202.

    Google Scholar 

  • Srivastava SK (1977) Tay-Sachs and Sandhoff diseases. In Glew RH and Peters SP, eds.Practical Enzymology of the Sphingolipidoses. New York: Alan R Liss, 217–241.

    Google Scholar 

  • Vogel F (1984) Clinical consequences of heterozygosity for autosomal recessive diseases.Clin Genet 25: 381–415.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michelakakis, H., Papadimitriou, A., Divaris, R. et al. Plasma lysosomal enzyme levels in patients with motor neuron disease. J Inherit Metab Dis 18, 72–74 (1995). https://doi.org/10.1007/BF00711376

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00711376

Keywords

Navigation